Tech Company Financing Transactions
Phoenix Biotechnology Funding Round
On 9/12/2010, Phoenix Biotechnology raised $1.1 million in funding from private investors.
Transaction Overview
Company Name
Announced On
9/12/2010
Transaction Type
Venture Equity
Amount
$1,120,600
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Advanced Materials
Mailing Address
8626 Tesoro Dr. 801
San Antonio, TX 78217
USA
San Antonio, TX 78217
USA
Phone
Website
Email Address
Overview
The company was created through the acquisition of the assets of Anvirlat, Inc., a privately held Nevada corporation controlled by Messrs. Addington and Kost, current officers and directors of the company.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Crandell Addington
Chief Information Officer
Carlos Torres
Chief Scientific Officer
Robert Newman
Executive Vice President
Lou Kost
Browse more venture capital transactions:
Prev: 9/10/2010: Good Start Genetics venture capital transaction
Next: 9/12/2010: Paloma Pharmaceuticals venture capital transaction
Share this article
Where The Data Comes From
We do our best to document every notable VC transaction. VC investment data records on this site are derived from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs